Kinetics of drug selection systems in mouse embryonic stem cells

BMC Biotechnology

Volumn 13, Issue , 2013, Pages

  Nakatake, Yuhki ^a,b   Fujii, Setsuko ^a,e   Masui, Shinji ^a,c   Sugimoto, Toshimi ^a,d   Torikai Nishikawa, Satomi ^a   Adachi, Kenjiro ^a   Niwa, Hitoshi ^a,d,e  

^a RIKEN   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Expression; Gene targeting; Marker; Transgene; Vector

Indexed keywords

DRUG RESISTANCE GENES; DRUG RESISTANT GENES; EXPERIMENTAL STRATEGY; EXPRESSION; GENE TARGETING; MARKER; MOUSE EMBRYONIC STEM CELLS; TRANSGENE;

DRUG DOSAGE; GENETIC ENGINEERING; MAMMALS; VECTORS;

GENE EXPRESSION;

ENHANCED GREEN FLUORESCENT PROTEIN; KRUPPEL LIKE FACTOR 4; PUROMYCIN;

ALLELE; ARTICLE; CELL DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESISTANCE; ELECTROPORATION; EMBRYO; EMBRYONIC STEM CELL; ENCEPHALOMYOCARDITIS VIRUS; EXPRESSION VECTOR; FLOW CYTOMETRY; FUSION GENE; GENE CASSETTE; GENE CONVERSION; GENE EXPRESSION; GENE TARGETING; HETEROZYGOTE; HOUSEKEEPING GENE; KINETICS; MARKER GENE; MOUSE; NONHUMAN; PROMOTER REGION; TRANSGENE;

ANIMALS; BIOTECHNOLOGY; DRUG RESISTANCE; EMBRYONIC STEM CELLS; GENE TARGETING; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; KINETICS; MICE; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; SELECTION, GENETIC; TRANSGENES;

EID: 84881052569     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-13-64     Document Type: Article

References (30)

1. Hartman SC, Mulligan RC. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc Natl Acad Sci USA 1988, 85(21):8047-8051. 10.1073/pnas.85.21.8047, 282351, 3054879.
2. Kimura M, Kamakura T, Tao QZ, Kaneko I, Yamaguchi I. Cloning of the blasticidin S deaminase gene (BSD) from Aspergillus terreus and its use as a selectable marker for Schizosaccharomyces pombe and Pyricularia oryzae. Mol Gen Genet 1994, 242(2):121-129. 10.1007/BF00391004, 8159161.
3. Mulsant P, Gatignol A, Dalens M, Tiraby G. Phleomycin resistance as a dominant selectable marker in CHO cells. Somat Cell Mol Genet 1988, 14(3):243-252. 10.1007/BF01534585, 2453083.
4. Sugden B, Marsh K, Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 1985, 5(2):410-413. 366725, 2983194.
5. Vara JA, Portela A, Ortin J, Jimenez A. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res 1986, 14(11):4617-4624. 10.1093/nar/14.11.4617, 311469, 3714487.
6. Yenofsky RL, Fine M, Pellow JW. A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure. Proc Natl Acad Sci USA 1990, 87(9):3435-3439. 10.1073/pnas.87.9.3435, 53915, 2159150.
7. Reitman M, Lee E, Westphal H, Felsenfeld G. Site-independent expression of the chicken beta A-globin gene in transgenic mice. Nature 1990, 348(6303):749-752. 10.1038/348749a0, 2175398.
8. Jang SK, Davies MV, Kaufman RJ, Wimmer E. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol 1989, 63(4):1651-1660. 248413, 2538648.
9. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998, 12(13):2048-2060. 10.1101/gad.12.13.2048, 316954, 9649508.
10. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199. 10.1016/0378-1119(91)90434-D, 1660837.
11. Masui S, Ohtsuka S, Yagi R, Takahashi K, Ko MS, Niwa H. Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells. BMC Dev Biol 2008, 8:45. 10.1186/1471-213X-8-45, 2386458, 18433507.
12. Niwa H, Ogawa K, Shimosato D, Adachi K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460(7251):118-122. 10.1038/nature08113, 19571885.
13. Tsakiridis A, Tzouanacou E, Larralde O, Watts TM, Wilson V, Forrester L, Brickman JM. A novel fusion reporter system for use in gene trap mutagenesis. Genesis 2007, 45(6):353-360. 10.1002/dvg.20301, 17492751.
14. Mountford P, Zevnik B, Duwel A, Nichols J, Li M, Dani C, Robertson M, Chambers I, Smith A. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci USA 1994, 91(10):4303-4307. 10.1073/pnas.91.10.4303, 43773, 8183905.
15. Gossler A, Joyner AL, Rossant J, Skarnes WC. Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science 1989, 244(4903):463-465. 10.1126/science.2497519, 2497519.
16. Skarnes WC, von Melchner H, Wurst W, Hicks G, Nord AS, Cox T, Young SG, Ruiz P, Soriano P, Tessier-Lavigne M, et al. A public gene trap resource for mouse functional genomics. Nat Genet 2004, 36(6):543-544. 10.1038/ng0604-543, 2716026, 15167922.
17. Martello G, Sugimoto T, Diamanti E, Joshi A, Hannah R, Ohtsuka S, Gottgens B, Niwa H, Smith A. Esrrb is a pivotal target of the gsk3/tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012, 11(4):491-504. 10.1016/j.stem.2012.06.008, 3465555, 23040478.
18. Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 2008, 135(5):909-918. 10.1242/dev.017400, 18263842.
19. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95(3):379-391. 10.1016/S0092-8674(00)81769-9, 9814708.
20. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007, 9(6):625-635. 10.1038/ncb1589, 17515932.
21. Taniguchi Y, Amazaki M, Furuyama T, Yamaguchi W, Takahara M, Saino O, Wada T, Niwa H, Tashiro F, Miyazaki J, et al. Sema4D deficiency results in an increase in the number of oligodendrocytes in healthy and injured mouse brains. J Neurosci Res 2009, 87(13):2833-2841. 10.1002/jnr.22124, 19472224.
22. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki Ji J, Hirota S, Kitamura Y, et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002, 99(6):3657-3662. 10.1073/pnas.022017899, 122579, 11891274.
23. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA 1999, 96(21):12114-12119. 10.1073/pnas.96.21.12114, 18421, 10518585.
24. Tateishi S, Niwa H, Miyazaki J, Fujimoto S, Inoue H, Yamaizumi M. Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells. Mol Cell Biol 2003, 23(2):474-481. 10.1128/MCB.23.2.474-481.2003, 151530, 12509447.
25. Nishiyama A, Xin L, Sharov AA, Thomas M, Mowrer G, Meyers E, Piao Y, Metha S, Yee S, Nakatake Y, et al. Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell 2009, 5(4):420-433. 2770715, 19796622.
26. Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA, Seidman JG. Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 1992, 12(5):2391-2395. 364411, 1569957.
27. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24(4):372-376. 10.1038/74199, 10742100.
28. Niwa H, Masui S, Chambers I, Smith AG, Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol 2002, 22(5):1526-1536. 10.1128/MCB.22.5.1526-1536.2002, 134688, 11839818.
29. Bevis BJ, Glick BS. Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat Biotechnol 2002, 20(1):83-87. 10.1038/nbt0102-83, 11753367.
30. Nichols J, Evans EP, Smith AG. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 1990, 110(4):1341-1348.